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Purpose: The objective of this study was to review clinical outcomes of minimally invasive
endoscopic resection (MIER) for anterior skull base (ASB) malignant neoplasms.
Study Design: Retrospective.
Materials and Methods: Data analysis was performed on all patients undergoing MIER
from October 2010 to October 2014.
Results: Thirty-one patients with mean age of 54 years underwent MIER. Malignant tumors
were managed endoscopically in all cases. Most common histopathologies were squamous
cell carcinoma (ten), sinonasal undifferentiated carcinoma (eight), esthesioneuroblastoma
(five), and mucosal melanoma (three). Surgical resection (MIER) with curative intent was
performed in all cases. Multilayered skull base reconstruction was performed in most
patients. American Joint Committee on Cancer tumor staging was used. Twenty five
patients were disease free, three patients were dead from disease, and three patients were
alive with disease.
Conclusions: This study validated technical feasibility of MIER for different anterior skull
base malignant neoplasms. Patients were able to avoid adjunct craniotomy and its
complications. MIER resulted in low complication rate and acceptable disease- free survival
in patients with advanced tumors.
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INTRODUCTION
Malignancies of the nasal cavity and paranasal sinuses
represent a rare, yet challenging, disease process. The
most common histopathological types of sinonasal
malignancy include squamous cell carcinoma,
adenocarcinoma, and olfactory neuroblastoma. While
prognostic factors differ among histological types, the
fundamental goal of any oncologic procedure is to resect
the tumor burden while obtaining adequate margins. [1]
Traditionally, craniofacial resection has been employed
in the surgical management of such malignancies.
However, as endoscopic excision of inverted papilloma,
juvenile nasopharyngeal angiofibroma, and benign
sinonasal lesions have demonstrated similar recurrence
rates to open approaches, these techniques have begun
to be implemented for selected sinonasal malignancies
at some institutions. [2] Early results of these evolving
techniques are promising, but significant controversy
exists. [3,4] It is argued that the endonasal approach
does not permit the surgeon to obtain acceptable
oncologic results, and is, therefore, not an acceptable
application for malignant sinonasal disease. Concern
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has also been expressed regarding the ability to obtain
adequate margins, hemostasis, and reconstruction
through an inherently limited surgical approach. [5]
Minimally invasive surgery for neoplasms of the
anterior skull base has revolutionized the treatment of
these diseases. The relative effect of endoscopic
procedures, however, has not been described in terms of
disease-specific and global health-related quality of life
(QoL). [6]
In recent years, endoscopic endonasal techniques have
been applied to the treatment of sinonasal malignancies.
Comprehensive anatomical knowledge is essential to
preserve oncological principles and minimize surgical
morbidity.
The bones that form the anterior cranial base are
pneumatized and the sinuses provide surgical corridors
for the endoscopic endonasal approach to the skull base.
During endoscopic endonasal resection of sinonasal
malignancies, usually, the intranasal portion of the
tumor is first debulked to provide visualization of the
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margins and assess the extent of the tumor. Afterwards
the tumor is completely removed and the margins of
resection are defined. Sinonasal malignant neoplasms
that invade the skull base can be resected accordingly to
oncological principles using endoscopic endonasal
techniques. [7]

PATIENTS AND METHODS
Retrospective chart review was performed on 31
patients undergoing MIER from October 2010 to May
2014 at Mansoura University hospital. Data collected
included patient demographics, tumor characteristics
(histopathology, TNM staging according to American
Joint Committee of Cancer), and surgical data
(intraoperative
findings,
skull
base
defects,
reconstruction, surgical margins, complications), and
postoperative therapies. Patient outcomes were
assessed, including recurrences, salvage surgery, and
long-term status (disease free, alive with disease, dead
of disease, dead from other causes).

RESULTS
Patient Demographics
The mean age for the 31 patients was 54 years
(Range, 34 to71 years). 20 male and 11 female, the mean
follow-up was 37.2 months (range, 12 to 76 months).
Table 1

Thirteen major complications were encountered in 13
patients (%). The complications and their management
are listed in Table 3.
Postoperative cerebrospinal fluid (CSF) leaks were
noted in 7 cases (%). Skull base reconstruction was
performed in 7 cases. Reconstruction was multilayered
in all these 7 cases. Nasoseptal flaps were used in 7
cases.
Postoperative radiation therapy was utilized in 7
patients.
Postoperative radiochemotherapy was employed in 9
patients.
Seven patients developed recurrences. Recurrences were
classified as local in 3 patients, regional in two patients
(cervical nodes), and distant in two patients (one hepatic
and one2 bony) metastases. Two skull base recurrences
were managed by craniotomy and endoscopic-assisted
craniotomy. One recurrence of SCC on the lateral nasal
wall was salvaged by endoscopic resection with orbital
exentrations dissection. (Figs. 1-5)
Table 1 Demographic and tumor Characteristics of 31
Patients Who Underwent Endoscopic Resection of
Sinonasal Cancer Characteristic Value
Treatment
Sex
Female

No. (%) of patients
11

Male

SITE OF ORIGIN AND EXTENT OF TUMOR
The most common site of origin (epicenter) of the tumor
was the nasal cavity and maxillary sinus (59 %) and the
ethmoid sinuses (28 %). Tumors originating from the
sphenoid sinus (10 %) or frontal sinus (3 %) were less
common, Skull base erosion in all patients. Tumors
extended to intracranial cavity in 5 patients, skull base
reconstruction with nasoseptal flap and middle
turbinate rotational flap technique for (7patients).
Surgiceal and gelfoam were added for further support.
Tumor Characteristics
The histopathology for the 31 cases is shown in Table 2.
The staging was T3N0MO and T4N0M0 in 20 (64.5%)
and 11(35.5%) patients, respectively. Previous surgery
was performed in 3 patients.
Surgical Parameters and Adjunct Therapies

20

Mean follow-up, mo

37.2

Prior treatment

5

Tumor stage
T stage, %
T1
T2
T3N0M0

20

T4N0M0

11

Previous surgery
No

28

Yes

3

Margins
Negative

26

Positive

5

Adjuvant treatment
None

15

Postop. radiation therapy

7

Postop. chemoradiation therapy

9

Recurrence

Twenty-seven patients (87%) were treated for curative
intent, whereas 4 cases (13%) were managed for
palliative intent. Adjunct procedures performed
included orbital decompression (5 patients), endoscopic
orbital exenteration (one patient), and staged
craniotomy (2 patients).
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Local

3

Regional

2

Distant

2

Disease-specific survival
3-year

77.5%
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Table 2 Tumor Histopathology for the 31 Cases
Histopathology

Number

Percentage

Squamous cell carcinoma

10

32,3%

Sinonasal undifferentiated
carcinoma

8

25,8%

Olfactory neuroblastoma

5

16,1%

Mucosal melanoma

3

9,7%

Adenocarcinoma

2

6,45%

Adenoid cystic carcinoma

2

6,45%

sarcoma

1

3,2 %

Table 3 Major Complications and Their Respective
Management
Complication
Cerebrospinal
leak

No. ( %)

Fig 2 Ct scans of same patient postoperatively

Management

fluid

7
(22, 58%)

Bed rest and lumbar
drain and nasoseptal
flaps

Pneumocephalus with
mental status changes

2
(6, 45%)

Conservative and
neurological
consultation

Meningitis

2
(6, 45%)

Intravenous antibiotics

Deep vein thrombosis

1
(3, 2%)

Anticoagulation

Diminution of vision

1
(3, 2%)

High dose of
corticosteroids

Fig 3 Erosion of the medial orbital wall and
protrusion of the orbital contents

Fig 1 Ct scans of squamous cell carcinoma of nose
and paranasal sinuses preoperatively
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Fig 4 Erosion of the medial orbital wall
with intact periosteum
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Interestingly, the Italian series, like most European
reports on sinonasal cancers, included a relatively large
number of patients with adenocarcinoma (37%), which
is less common in the United States and has a relatively
better prognosis than squamous cell carcinoma,
melanoma, and sinonasal undifferentiated carcinoma.
[12] They also described a shift in their selection of the
surgical approach in the latter part of their study,
extending the indications of exclusively endoscopic
approach to include selected patients with skull base
invasion and “focal” dural infiltration. In our series
squamous cell carcinoma, sinonasal undifferentiated
carcinoma and olfactory neuroblastoma were the most
common pathology.

Fig 5 Bone graft closing skull base defect in
cribriform plate of ethmoids

DISCUSSION
As the endoscopic techniques have been more widely
applied for tumor resection, several criticisms have been
leveled at MIER, including violation of the concept of en
bloc resection and a short track record The notion of en
bloc resection, although a worthy objective, is rarely
achievable. Generous margins are often not possible
given proximity to critical structures, and the delicate
ethmoid septations prevent the specimen from holding
together as a single large piece. Moreover, multiple
endoscopic series, employing the piecemeal approach
have not demonstrated compromise in survival. [8]
Ganly et al., CFR „„is not without significant morbidity.‟‟
[9]
Endoscopic resections of sinonasal cancers should be
performed by surgeons who have extensive experience
in 2 areas: endoscopic techniques and surgical oncologic
principles. Lack of expertise in either area should alert
the surgeon to an alternative management strategy. [10]
Endoscopic approaches to the skull base and sinonasal
regions offer several advantages. In addition to excellent
visualization, endoscopic approaches eliminate or
significantly reduce the need for craniofacial soft-tissue
dissection, skeletal disassembly, and brain retraction for
tumor access and resection. These advantages are
probably the impetus for the increasing adoption of
endoscopic approaches for surgical management of
sinonasal and skull base tumors. [5]
The surgical objectives of complete tumor removal must
be balanced with the goal of minimizing adverse impact
on QOL of patients. (Decreasing intraoperative
complications and minimizing long-term patient
morbidity and hospitalization time compared to the
open techniques). [4,11]
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Successful separation of the intracranial and sinonasal
compartments and elimination of potential cross
contamination are critical components to the success of
MIER with low complication rate. Multilayer skull base
reconstruction was employed in a majority of the cases
with an acceptable CSF leak rate of 6.5 %. [8]
In our series 22.5% of patients developed CSF
rhinorrhea, they were managed successfully with
nasoseptal flaps and multilayer closure.
Important contraindications of MIER include extensive
dural and/or parenchymal tumor infiltration and lateral
extension over the orbital roof; a bifrontal or subfrontal
craniotomy should be planned for these cases. Patients
with extensive facial soft-tissue, lacrimal pathway, or
anterior frontal sinus involvement may also be better
managed by an open technique. A combination of
endoscopic and external approaches may be offered for
some cases.
Relative contraindications include highly vascular
tumors, extensive bilateral disease, and significant
orbital or infratemporal fossa involvement; the decision
to employ MIER in these cases must be individualized
based on surgeon experience. [8] We think that
infratemporal fossa tumors can be accessed
endoscopically especially if there is no carotid sheath
affection.
MIER results in overall improvement in20-item SinoNasal Outcomes Test score (SNOT-20) SNOT-20 scores,
with greater change being noted in females and in
patients with benign tumors. Prior smoking and
chemoradiation
strongly
predict
decreased
improvement in sinonasal QOL after surgery. [13]
Revenaugh etal suggest a potential role for MIER in the
comprehensive management algorithm of SNUC in
appropriately selected patients. Patient outcomes
including local and regional recurrence, distant
metastases, and overall and disease-free survival were
comparable to a treatment strategy using traditional
craniofacial resection. [14]
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MIER of ASB neoplasia did not differ significantly from
traditional CFR in operative time, estimated blood loss,
hospital stay, or complication rate. Survival and
recurrence rates were similar also. This early experience
suggests that MIER is a viable alternative for the
surgical management of ASB lesions in appropriately
selected patients. [15]
MIER is not without complications, in our series we
have 13 major complications especially CSF rhinorrhea,
pneumocephlus, meningitis, deep venous thrombosis,
and diminution of vision. Hanna etal [10] reported
Postoperative cerebrospinal fluid (CSF) leakage in 4 of
120 patients (3%). The CSF leak in 3 patients resolved
spontaneously, and the fourth patient underwent
successful endoscopic repair. One patient had
meningitis, which resolved with antibiotic therapy.
Other less common complications included epiphora in
2 patients and dacryocystitis in 1 patient. Zhong etal [16]
reported high incidence of complications 87 of 178
patients, including cerebrospinal fluid rhinorrhea,
intracranial infections, diabetes insipidus, etc.
Eighty-five cases with complications recovered through
proper medical and nursing care, except for 2 cases of
death. The 3-year disease-free survival rates were 86.8%
in the endoscopic group and 67.7% in the open group
(p=0.047); however, the patients in the endoscopic
group had lower T stages (p = 0.0068) and lower ASA
scores
(p=0.03).
In
carefully
selected
patients, endoscopic approaches demonstrate survival
rates comparable to those of traditional surgery, and
fewer perioperative complications. [17]
Endoscopic endonasal resection performed with or
without a transcranial approach, when properly
planned and in expert hands, has an accepted role with
precise indications in the surgeon's armamentarium for
the treatment of sinonasal and skull base malignancies.
[18]
In patients with high-grade malignancies, a carefully
constructed multimodal treatment plan, incorporating
surgery, radiation therapy, and chemotherapy, is
necessary to maximize patients' outcomes. Postoperative
endoscopic follow up is a mandatory step to follow up
patients with thorough examination of all corners to
detect early recurrences and to clean extensive
crustations. Surgeons should be prepared for external
approach at any time as a complementary or alternative
one.

CONCLUSIONS
This study validated technical feasibility of MIER for
different anterior skull base malignant neoplasms.
Patients were able to avoid adjunct craniotomy and its
complications. MIER resulted in low complication rate
and acceptable disease- free survival in patients with
advanced tumors.
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The central concepts on surgical oncology must remain
paramount; regardless of the surgical approach. All
cases should be presented at the tumor board to devise
an optimal strategy for each individual case. The
surgeon must be comfortable incorporating endoscopic
and traditional open approaches, if required for specific
case scenarios. Selection of surgical approaches to
the anterior skull base is based upon balancing risk
reduction with maximizing extent of resection.

REFERENCES
1.

Higgins TS1, Thorp B, Rawlings BA, Han JK. Outcome
results of endoscopic vs craniofacial resection of
sinonasal malignancies: a systematic review and
pooled-data
analysis.
Int
Forum
Allergy
Rhinol. 2011;1:255-61.

2.

Busquets JM, Hwang PH. Endoscopic resection of
sinonasal inverted papilloma: a meta-analysis
Otolaryngol Head Neck Surg. 2006;134:476–482.

3.

Stammberger H, Anderhuber W, Walch C, et al.
Possibilities and limitations of endoscopic management
of nasal and paranasal sinus malignancies. Acta
Otorhinolaryngol. Belg. 1999;53:199–205.

4.

Lund VJ, Howard DJ, Wei WI. Endoscopic resection of
malignant tumors of the nose and sinuses. Am J Rhinol.
2007;21:89–94.

5.

Snyderman C, Carrau R, Kassam A, et al. Endoscopic
skull base surgery: principles of endonasal oncological
surgery. J Surg Oncol. 2008;97:658–664.

6.

Ransom ER, Doghramji L, Palmer JN, Chiu AG. Global
and disease-specific health-related quality of life after
complete endoscopic resection of anterior skull base
neoplasms. Am J Rhinol Allergy. 2012;26:76-9.

7.

Pinheiro-Neto
CD1, Fernandez-Miranda
JC, Wang
EW, Gardner
PA, Snyderman
CH.
Anatomical correlates of endonasal surgery for sinonas
al malignancies. Clin Anat. 2012;25:129-34.

8.

Batra PS1, Luong A, Kanowitz SJ, Sade B, Lee J, Lanza
DC, Citardi
MJ
Outcomes of minimally invasive endoscopic resection o
f anterior skull base neoplasms. Laryngoscope. 2010;
120:9-16.

9.

Ganly I, Patel SG, Singh B, et al. Complications of
craniofacial resection for malignant tumors of the skull
base: report of an international collaborative study.
Head Neck. 2005;27:445–451.

10.

Hanna E1, DeMonte F, Ibrahim S, Roberts D, Levine
N, Kupferman
M
Endoscopic resection of sinonasal cancers with
and
without craniotomy:
oncologic
results.
Arch
Otolaryngol Head Neck Surg. 2009;135:1219-24.

11.

Dave SP, Bared A, Casiano RR. Surgical outcomes and
safety of transnasal endoscopic resection for anterior
skull tumors. Otolaryngology Head Neck Surg.
2007;136: 920–927.

53

12.

Nicolai P, Battaglia P, Bignami M, et al. Endoscopic
surgery for malignant tumors of the sinonasal tract and
adjacent skull base: a 10-year experience. Am J Rhinol.
2008;22:308-316.

16.

Zhong Z1, Wang F, Li L, Tan G.
Management of
postoperative complications of
basicranial
tumor
resection under nasal endoscopy. Lin Chung Er Bi Yan
Hou Tou Jing Wai Ke Za Zhi. 2012;26:926-8.

13.

Harrow BR1, Batra PS. Sinonasal quality of life
outcomes after minimally invasive resection of
sinonasal and skull-base tumors. Int Forum Allergy
Rhinol. 2013;3:1013-20.

17.

Suh JD1, Ramakrishnan VR, Chi JJ, Palmer JN, Chiu AG
Outcomes and complications of endoscopic approaches
for malignancies of the paranasal sinuses and
anteriorskull
base.
Ann
Otol
Rhinol
Laryngol. 2013;122:54-9.

14.

Revenaugh PC1, Seth R, Pavlovich JB, Knott PD, Batra
PS. Minimally invasive endoscopic resection of
sinonasal
undifferentiated
carcinoma.
Am
J
Otolaryngol. 2011;32:464-9.

18.

Castelnuovo P1, Battaglia P2, Turri-Zanoni M1, Tomei
G3, Locatelli
D4, Bignami
M1, Bolzoni
Villaret
A5, Nicolai P5. Endoscopic Endonasal Surgery
for Malignancies of
the Anterior Cranial Base.World
Neurosurg. 2014;82:S22-S31.

15.

54

Batra PS1, Citardi MJ, Worley S, Lee J, Lanza DC.
Resection of anterior skull base tumors: comparison of
combined traditional and endoscopic techniques. Am J
Rhinol. 2005;19:521-8.

PAN Arab Journal of Rhinology

